Scientific Advisory Board

Paul Walker is the group leader of the laboratory of Immunobiology of Brain Tumours at the University of Geneva, Switzerland. He has published over 60 peer-reviewed research papers and several book chapters. His two main areas of research are T-cell homing and tumour microenvironment. He serves as a referee in more than 15 peer-reviewed journals including Cancer Research, Blood and Nature Reviews Immunology.

Hideho Okada is a Professor at the department of Neurological Surgery of the University of Pittsburgh, U.S, and co-leader of the Brain Tumour program at the University’s Cancer Institute. For more than 10 years, he has focused his efforts on the development of immunotherapies for brain tumours. His work has resulted in the identification of new glioma-associated antigens, enabling the launch of clinical trials with DC-based vaccines and polyIC as adjuvants.

Jean-Yves Bonnefoy has 30 years’ experience in the pharmaceutical industry directing research and development projects. Presently CEO of Anagenesis Biotechnologies, he has also held managerial positions for various academic, biotechnology and pharmaceutical companies across Europe.

Jean-Yves holds a PhD in Immunology and is author and co-author of more than 230 publications and reviews.